Alpine Immune Sciences Inc
NASDAQ:ALPN
| Market Cap (Intraday) | 4.23B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $58.36 |
| 50-Day MA | $39.83 |
| 200-Day MA | $20.97 |
Alpine Immune Sciences Inc Stock, NASDAQ:ALPN
188 East Blaine Street, Suite 200, Seattle, Washington 98102
United States of America
Phone: +1.206.788.4545
Number of Employees: 142
Description
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing innovative, protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.